Skip Main Navigation
Page Content

Save This Event

Event Saved

CLSA California Life Sciences Association

The Innovation Series: Expand Your Phase I Clinical Trial

California Life Sciences Institute

Wednesday, August 15, 2018 from 5:00 PM to 8:00 PM (PDT)

The Innovation Series: Expand Your Phase I Clinical...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Attendee (CLSA Member)
Member verification upon registration. Not sure if your company is a CLSA member? Visit http://bit.ly/2r7wU3g.
Aug 14, 2018 $5.00 $1.27
Attendee (CLSA Non-Member) Aug 14, 2018 $5.00 $1.27

Event Details

Expand Your Phase I Clinical Trial 

Please join CLSI, Nucleus Network, and guests for an educational presentation on expediting your Phase 1 Clinical Trial in Australia. 

Some compelling benefits for consideration are:

  •  Speed – you can have First-patient-in, in about 6 weeks, and you do not need an IND to commence
  •  Quality – Data generated is accepted by the FDA and EMA. Many file IND after Phase 1 with Data in hand.
  •  Cost – There is a 41% cash rebate for all work performed in Australia

 

Program Agenda

5:00pm                 Registration Opens

5:30pm                 Opening Remarks | Lori Lindburg, President & CEO, CLSI

5:40pm                 Panel Discussion

6:40pm                 Audience Q&A

7:00pm                 Networking Reception 

 

Panelist

Cameron Johnson
Chief Executive Officer and Managing Director, Nucleus Network

Cameron Johnson joined Nucleus Network in 2013 initially as the Chief Operating Officer before moving to the Chief Executive Officer position. Prior to working for Nucleus, Cameron was Chief Executive Officer of a Phase 1 Clinical Trials Organisation. Ultimately responsible for the growth and success of the company, he led the organization to win the 2013 Western Australia’s Industry and Export Premiers Award for Excellence. Other awards include Western Australia’s Industry and Export Award for Healthcare and Biotechnology and Western Australia’s Industry and Export Award for Emerging Exporter of 2012.

Cameron has worked extensively in early phase clinical trials across Australia, Europe, and the US for over 17 years. He is a member of the Australian Institute of Company Directors and The Executive Connection (TEC).


 

In Partnership With: 



Have questions about The Innovation Series: Expand Your Phase I Clinical Trial ? Contact California Life Sciences Institute

Save This Event

Event Saved

When & Where


CLSI
701 Gateway, Suite 440
South San Francisco, CA

Wednesday, August 15, 2018 from 5:00 PM to 8:00 PM (PDT)


  Add to my calendar

Organizer

California Life Sciences Institute

California Life Sciences Institute (CLSI) supports the foundations of innovation that have made California home to the world’s most prominent life sciences ecosystem. Our mission is to maintain California’s leadership in life sciences innovation through support of entrepreneurship, education and career development. CLSI also serves as an accelerator for CARB-X, the world’s largest public-private partnership devoted to early stage antibacterial R&D.

 

CLSI is an affiliate of the California Life Sciences Association (CLSA), which represents California’s leading life sciences organizations. The California Life Sciences Institute is a non-profit 501(c)(3), and was established in 1990 as the BayBio Institute. Any contribution made to our organization is deductible as charitable contributions for federal income tax purposes.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.